Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #381 to #430.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Isotropic geometry‏‎ (2 revisions)
  2. Endogeneous excretion‏‎ (2 revisions)
  3. Lineal energy‏‎ (2 revisions)
  4. Thyroid blocking‏‎ (2 revisions)
  5. Exposure to Radon at Home‏‎ (2 revisions)
  6. Transparency‏‎ (2 revisions)
  7. GATA binding protein 2‏‎ (2 revisions)
  8. Waste disposal‏‎ (2 revisions)
  9. Non-targeted effects‏‎ (2 revisions)
  10. Hormones‏‎ (2 revisions)
  11. Authorization‏‎ (2 revisions)
  12. Procedural values‏‎ (2 revisions)
  13. Clonogenic cells‏‎ (2 revisions)
  14. Reasonableness‏‎ (2 revisions)
  15. Cytokines‏‎ (2 revisions)
  16. Residual dose‏‎ (2 revisions)
  17. Safety culture‏‎ (2 revisions)
  18. Solar cosmic radiation‏‎ (2 revisions)
  19. Inhalability‏‎ (2 revisions)
  20. Spontaneous fission‏‎ (2 revisions)
  21. Itinerant (radiation) worker‏‎ (2 revisions)
  22. Linear-non-threshold model‏‎ (2 revisions)
  23. Trapped particles‏‎ (2 revisions)
  24. Acute radiation syndrome‏‎ (2 revisions)
  25. Orphan source‏‎ (2 revisions)
  26. Hounsfield unit‏‎ (2 revisions)
  27. Authorized limit‏‎ (2 revisions)
  28. Planned exposure situation‏‎ (2 revisions)
  29. Progenitor cell‏‎ (2 revisions)
  30. Cardiac arrhythmias‏‎ (2 revisions)
  31. Radiation belt‏‎ (2 revisions - redirect page)
  32. Clonogenic survival‏‎ (2 revisions)
  33. Respiratory protection‏‎ (2 revisions)
  34. Disposal‏‎ (2 revisions)
  35. Scintigraphy‏‎ (2 revisions)
  36. Dose criteria‏‎ (2 revisions)
  37. Solar cycle‏‎ (2 revisions)
  38. Inner bremsstrahlung‏‎ (2 revisions)
  39. Environmental exposure‏‎ (2 revisions)
  40. Systemic model‏‎ (2 revisions)
  41. Linear-quadratic dose response model‏‎ (2 revisions)
  42. Exempt waste‏‎ (2 revisions)
  43. Time factor‏‎ (2 revisions)
  44. Myocardial perfusion‏‎ (2 revisions)
  45. Adaptive response‏‎ (2 revisions)
  46. What is Radon?‏‎ (2 revisions)
  47. Alveolar-interstitial region‏‎ (2 revisions)
  48. Autoimmune disease‏‎ (2 revisions)
  49. Platelet-derived growth factor‏‎ (2 revisions)
  50. ICRP Publication 118‏‎ (2 revisions)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)